South Africa Prediabetes Market Size & Outlook, 2023-2030
South Africa prediabetes market, 2018-2030 (US$M)
Related Markets
South Africa prediabetes market highlights
- The South Africa prediabetes market generated a revenue of USD 1.0 million in 2023 and is expected to reach USD 1.2 million by 2030.
- The South Africa market is expected to grow at a CAGR of 3.7% from 2024 to 2030.
- In terms of segment, diguanide was the largest revenue generating drug class in 2023.
- Diguanide is the most lucrative drug class segment registering the fastest growth during the forecast period.
Prediabetes market data book summary
| Market revenue in 2023 | USD 1.0 million |
| Market revenue in 2030 | USD 1.2 million |
| Growth rate | 3.7% (CAGR from 2023 to 2030) |
| Largest segment | Diguanide |
| Fastest growing segment | Diguanide |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diguanide, Thiazolidinediones, Glucagon-like peptide-1 agonists (GLP-1), SGLT2 inhibitors , DPP-4 inhibitors, Other Drug Classes |
| Key market players worldwide | Novo Nordisk A/S ADR, Resverlogix Corp, AstraZeneca PLC, Bristol-Myers Squibb Co, Valbiotis, Caelus Health, SciMar, Boston Therapeutics, Aphaia |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.5% of the global prediabetes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia prediabetes market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 0.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Prediabetes Market Scope
Prediabetes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa prediabetes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to prediabetes market will help companies and investors design strategic landscapes.
Diguanide was the largest segment with a revenue share of 80% in 2023. Horizon Databook has segmented the South Africa prediabetes market based on diguanide, thiazolidinediones, glucagon-like peptide-1 agonists (glp-1), sglt2 inhibitors , dpp-4 inhibitors, other drug classes covering the revenue growth of each sub-segment from 2018 to 2030.
- South Africa Prediabetes Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Diguanide
- Thiazolidinediones
- Glucagon-like peptide-1 agonists (GLP-1)
- SGLT2 inhibitors
- DPP-4 inhibitors
- Other Drug Classes
- South Africa Prediabetes Age Group Outlook (Revenue, USD Million, 2018-2030)
- Children (12-18 years)
- Adults (18-49)
- Elderly (50+)
Reasons to subscribe to South Africa prediabetes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa prediabetes market databook
-
Our clientele includes a mix of prediabetes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa prediabetes market , including forecasts for subscribers. This country databook contains high-level insights into South Africa prediabetes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa prediabetes market size, by drug class, 2018-2030 (US$M)
South Africa Prediabetes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
